We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
IPCALAB.NSE

Price
1330.95
Stock movement up
+36.10 (2.79%)
Company name
IPCA Laboratories Limited
Exchange
(NSE
,
Currency
INR
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
337.67B
Ent value
368.17B
Price/Sales
3.96
Price/Book
4.16
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
51.07
Forward P/E
36.84
PEG
-
EPS growth
7.96%
1 year return
2.82%
3 year return
10.26%
5 year return
15.03%
10 year return
15.78%
Last updated: 2025-04-12

DIVIDENDS

IPCALAB.NSE does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E51.07
Price to OCF169.68
Price to FCF169.68
Price to EBITDA95.45
EV to EBITDA104.07

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales3.96
Price to Book4.16
EV to Sales4.31

FINANCIALS

Per share

Per share data
Current share count253.70M
EPS (TTM)26.08
FCF per share (TTM)7.85

Income statement

Income statement data
Revenue (TTM)85.33B
Gross profit (TTM)45.98B
Operating income (TTM)13.14B
Net income (TTM)6.61B
EPS (TTM)26.08
EPS (1y forward)36.13

Margins

Margins data
Gross margin (TTM)53.88%
Operating margin (TTM)15.39%
Profit margin (TTM)7.75%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash2.56B
Net receivables0.00
Total current assets56.81B
Goodwill905.80M
Intangible assets1.41B
Property, plant and equipment0.00
Total assets114.24B
Accounts payable9.06B
Short/Current long term debt12.02B
Total current liabilities23.96B
Total liabilities33.06B
Shareholder's equity81.18B
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.99B
Capital expenditures (TTM)0.00
Free cash flow (TTM)1.99B
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity8.15%
Return on Assets5.79%
Return on Invested Capital7.49%
Cash Return on Invested Capital2.25%

STOCK INFORMATION

Stock chart

Stock price data
Open1327.95
Daily high1355.35
Daily low1307.40
Daily Volume140K
All-time high1744.05
1y analyst estimate1564.37
Beta0.23
EPS (TTM)26.08
Dividend per share-
Ex-div date27 Nov 2024
Next earnings date5 May 2025

Downside potential

Downside potential data
IPCALAB.NSES&P500
Current price drop from All-time high-23.69%-12.89%
Highest price drop-86.27%-56.47%
Date of highest drop17 Sep 20019 Mar 2009
Avg drop from high-30.61%-11.07%
Avg time to new high29 days12 days
Max time to new high2161 days1805 days
COMPANY DETAILS
IPCALAB.NSE (IPCA Laboratories Limited) company logo
Marketcap
337.67B
Marketcap category
Large-cap
Description
Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, hematology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.
Employees
17335
Website
https://www.ipca.com
Investor relations
-
SEC filings
IPCALAB.NSE SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved